A multi-site clinical trial found pharmacist integration into primary care teams for opioid use disorder was feasible and acceptable, with modest improvements in treatment retention and adherence. The results support a team-based care model that can be deployed without relying solely on specialized opioid clinics. The study adds operational detail for how primary care can scale addiction care, potentially improving real-world outcomes where access and continuity remain major constraints.